Author
Listed:
- Xiaofeng Wang
(Dartmouth College
Dana-Farber Cancer Institute)
- Su Wang
(Harvard Medical School)
- Emma C. Troisi
(Dana-Farber Cancer Institute)
- Thomas P. Howard
(Dana-Farber Cancer Institute
Broad Institute of Harvard and MIT)
- Jeffrey R. Haswell
(Dana-Farber Cancer Institute)
- Bennett K. Wolf
(Dartmouth College)
- William H. Hawk
(Dartmouth College)
- Pilar Ramos
(St. Jude Children’s Research Hospital)
- Elaine M. Oberlick
(Dana-Farber Cancer Institute)
- Evgeni P. Tzvetkov
(Dana-Farber Cancer Institute)
- Aaron Ross
(St. Jude Children’s Research Hospital)
- Francisca Vazquez
(Broad Institute of Harvard and MIT)
- William C. Hahn
(Broad Institute of Harvard and MIT
Dana-Farber Cancer Institute)
- Peter J. Park
(Harvard Medical School)
- Charles W. M. Roberts
(Dana-Farber Cancer Institute
St. Jude Children’s Research Hospital)
Abstract
Bromodomain-containing protein 9 (BRD9) is a recently identified subunit of SWI/SNF(BAF) chromatin remodeling complexes, yet its function is poorly understood. Here, using a genome-wide CRISPR-Cas9 screen, we show that BRD9 is a specific vulnerability in pediatric malignant rhabdoid tumors (RTs), which are driven by inactivation of the SMARCB1 subunit of SWI/SNF. We find that BRD9 exists in a unique SWI/SNF sub-complex that lacks SMARCB1, which has been considered a core subunit. While SMARCB1-containing SWI/SNF complexes are bound preferentially at enhancers, we show that BRD9-containing complexes exist at both promoters and enhancers. Mechanistically, we show that SMARCB1 loss causes increased BRD9 incorporation into SWI/SNF thus providing insight into BRD9 vulnerability in RTs. Underlying the dependency, while its bromodomain is dispensable, the DUF3512 domain of BRD9 is essential for SWI/SNF integrity in the absence of SMARCB1. Collectively, our results reveal a BRD9-containing SWI/SNF subcomplex is required for the survival of SMARCB1-mutant RTs.
Suggested Citation
Xiaofeng Wang & Su Wang & Emma C. Troisi & Thomas P. Howard & Jeffrey R. Haswell & Bennett K. Wolf & William H. Hawk & Pilar Ramos & Elaine M. Oberlick & Evgeni P. Tzvetkov & Aaron Ross & Francisca Va, 2019.
"BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors,"
Nature Communications, Nature, vol. 10(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09891-7
DOI: 10.1038/s41467-019-09891-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09891-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.